| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/15/1992 | EP0466029A2 Inflammatory bowel disease preventive and curative agents containing zinc l-carnosine salt or complex as active ingredient |
| 01/15/1992 | EP0465979A1 Anti HTLV-III (strain MN) monoclonal antibody |
| 01/15/1992 | EP0465895A1 WS7622A di- sulfate, process for preparation thereof and use thereof |
| 01/15/1992 | EP0465633A1 C4 binding protein fusion proteins |
| 01/15/1992 | EP0465602A1 METHOD FOR DETECTION AND/OR IDENTIFICATION OF $i(LYSSAVIRUS) INFECTIONS, CLONING AND EXPRESSION OF GENES CODING FOR PEPTIDES AND/OR FRAGMENTS OF PEPTIDES OF MOKOLA $i(LYSSAVIRUS), VACCINE AGAINST THE MOKOLA VIRUS AND/OR THE FAMILY OF $i(LYSSAVIRUSES) AS WELL AS METHOD FOR OBTAINING SAID VACCINE VIA |
| 01/15/1992 | EP0465539A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 01/15/1992 | EP0465529A1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 01/15/1992 | EP0465495A1 Ribozome inactivating proteins and derivatives thereof |
| 01/15/1992 | EP0462205A4 Leukocyte adhesion receptors |
| 01/15/1992 | EP0235162B1 Cdna and gene for human angiogenin (angiogenesis factor) and methods of expression |
| 01/15/1992 | CN1057862A Muteins of granulocyte colony stimulating factor |
| 01/15/1992 | CN1057784A Growth hormone releasing factor analogs |
| 01/14/1992 | WO1992001039A1 Promotion of maturation of hematopoietic progenitor cells |
| 01/14/1992 | WO1992000998A1 Growth hormone crystals and a process for production of these gh-crystals |
| 01/14/1992 | WO1992000753A1 PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9 |
| 01/14/1992 | US5081284 N-Oxomethyl-Substituted Peptide |
| 01/14/1992 | US5081235 Chimeric anti-cea antibody |
| 01/14/1992 | US5081225 Gram-positive and gram-negative antibacterial compounds from the microorganism, janthinobacterium lividum |
| 01/14/1992 | US5081156 Sustained-release preparation |
| 01/14/1992 | US5081149 Antihepatopathic method |
| 01/14/1992 | US5081108 Method of showing progression of AIDS in an ARC patient by treating with Tyr-Gly compositions |
| 01/14/1992 | US5081107 Bombesin or bombesin-like peptides antagonists; anticarcinogenic agents; antisecretory agents; glandular disorders |
| 01/14/1992 | US5081105 Method of treating cancer using structured lipids |
| 01/14/1992 | US5081034 Genetic engineering |
| 01/14/1992 | US5081031 Synthetic polypeptide with type iv collagen activity |
| 01/14/1992 | US5081028 Preparation of transformed hosts which express binding factor related polypeptides |
| 01/14/1992 | US5081021 DNA encoding HTNF variants exhibiting enhanced activity |
| 01/14/1992 | US5081020 DNA sequences, genetic engineering and polypeptides for bovine growth hormones |
| 01/14/1992 | US5081019 DNA sequences, recombinant DNA molecules and processes for producing lipocortin-like polypeptides |
| 01/14/1992 | US5080909 Lithium Salt, Vidarabine, Synergistic |
| 01/14/1992 | US5080907 Pharmaceutical preparations containing non-steroidal anti-inflammatory agents |
| 01/14/1992 | US5080904 Drug delivery |
| 01/14/1992 | US5080898 Enzymatically active toxin coupled to a cell-specific ligand |
| 01/14/1992 | US5080895 Specific antibody-containing substance from eggs and method of production and use thereof |
| 01/14/1992 | US5080894 Injection of ethylene oxide-propylene oxide copolymer and oxygen free radical scavenger; antiischemic agents |
| 01/14/1992 | US5080891 Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
| 01/14/1992 | US5080886 Pharmaceutical compositions for the prevention and treatment of oxidant injuries |
| 01/14/1992 | CA2087190A1 Parathyroid hormone analogues modified at positions |
| 01/14/1992 | CA2087170A1 Promotion of maturation of hematopoietic progenitor cells |
| 01/14/1992 | CA1294369C Selective calling radio display pager having a message recalling algorithm which simplifies operations |
| 01/14/1992 | CA1294232C Process for preparing glucagon or derivatives or fragments thereof in yeast |
| 01/14/1992 | CA1294218C Method and agents for inhibiting protein aging |
| 01/14/1992 | CA1294215C Pharmaceutical compositions of recombinant beta-interferon and formulation processes |
| 01/11/1992 | WO1992001055A1 O-glycosylated ifn-alpha |
| 01/11/1992 | WO1992000754A1 Igf-1 and related compounds in pregnancy |
| 01/11/1992 | WO1992000752A1 Treatment of male infertility |
| 01/11/1992 | CA2087030A1 Igf-1 and related compounds in pregnancy |
| 01/11/1992 | CA2087026A1 Treatment of male infertility |
| 01/11/1992 | CA2084514A1 O-glycosylated ifn-alpha |
| 01/10/1992 | WO1992000996A1 Derivatives of pituitary posterior lobe hormones |
| 01/10/1992 | WO1992000995A1 Cyclic cell adhesion modulation compounds |
| 01/10/1992 | CA2087021A1 Cyclic cell adhesion modulation compounds |
| 01/10/1992 | CA2085603A1 Derivatives of pituitary posterior lobe hormones |
| 01/09/1992 | WO1992000387A1 Neurofibromatosis gene |
| 01/09/1992 | WO1992000383A1 Antibodies specific for the transglutaminase-induced isopeptide bond |
| 01/09/1992 | WO1992000382A1 Gdf-1 |
| 01/09/1992 | WO1992000378A1 Dna sequence for a serine protease and associated items |
| 01/09/1992 | WO1992000376A1 Mast cell growth factor |
| 01/09/1992 | WO1992000330A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 01/09/1992 | WO1992000329A1 Surface complexed lymphotoxin |
| 01/09/1992 | WO1992000327A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(a) |
| 01/09/1992 | WO1992000326A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(b) |
| 01/09/1992 | WO1992000325A1 Anticoagulant polypeptides |
| 01/09/1992 | WO1992000324A1 Novel protein capable of causing differential growth of cell and production thereof by genetic engineering technology |
| 01/09/1992 | WO1992000322A1 Insulin analogues with organ preferential action |
| 01/09/1992 | WO1992000321A1 Novel, protracted insulin analogues |
| 01/09/1992 | WO1992000094A1 Method of treating nausea and emesis related to motion sickness |
| 01/09/1992 | WO1992000093A1 Transfer factor and methods of use |
| 01/09/1992 | WO1992000092A1 Ligand for cd28 receptor on b cells and methods |
| 01/09/1992 | WO1992000091A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 01/09/1992 | WO1992000090A1 Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase |
| 01/09/1992 | WO1992000088A1 Bile acid secretagogue |
| 01/09/1992 | WO1992000087A1 Process for obtaining pure peptide transfer factor, transfer factor thus obtained and uses thereof |
| 01/09/1992 | WO1992000084A1 Substantially pure placental derived endothelial cell growth factor and uses thereof |
| 01/09/1992 | WO1992000055A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 01/09/1992 | DE4020144A1 Patches for topical or transdermal drug delivery - with adhesive layer contg. polyacrylate adhesive and film former |
| 01/09/1992 | DE4014063A1 Dekontaminiertes biologisches material Decontaminated biological material |
| 01/09/1992 | CA2086610A1 Transfer factor and methods of use |
| 01/09/1992 | CA2086334A1 Neurofibromatosis gene |
| 01/09/1992 | CA2086091A1 Human macrophage inflammatory protein 2o |
| 01/09/1992 | CA2086088A1 Human macrophage inflammatory protein 2.beta. |
| 01/09/1992 | CA2084510A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 01/09/1992 | CA2084413A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 01/08/1992 | EP0465097A2 Peptides having atrial natriuretic factor activity |
| 01/08/1992 | EP0464590A2 Inhibition of coloration of human serum albumin |
| 01/08/1992 | EP0464573A1 Plaster high in softening substances |
| 01/08/1992 | EP0464549A1 Calcitonin analogues and use thereof |
| 01/08/1992 | EP0464533A1 Fusionproteins with parts of immunoglobulins, their production and use |
| 01/08/1992 | EP0464517A2 Amino acid derivatives with renin inhibiting activity |
| 01/08/1992 | EP0464175A1 Extracellular form of the human fibroblast growth factor receptor |
| 01/08/1992 | EP0464147A1 Matrix metalloproteinase inhibitor peptides |
| 01/08/1992 | EP0464135A1 Method for reducing side effects of a drug. |
| 01/08/1992 | EP0464022A1 Insulinotropic hormone |
| 01/08/1992 | EP0462184A4 Method of treating viral infections using lfa-1 |
| 01/08/1992 | CN1057655A Ws7622a mono-or di-sulfate, process for preparation thereof and use thereof |
| 01/07/1992 | WO1992001001A1 Production of outer membrane (om) proteins in gram-positive bacteria and recovery of protective epitopes |
| 01/07/1992 | WO1992000750A1 Retroviral protease inhibitors |
| 01/07/1992 | WO1992000739A1 3-phenyl-5,6-dihydrobenz[c]acridine-7-carboxylic acids and related compounds as immunosuppresive agents |
| 01/07/1992 | US5079366 Quarternary pyridinium salts |
| 01/07/1992 | US5079345 Proteins having growth hormone anabolic properties with reduced effect on carbohydrate metabolism |